Literature DB >> 8566864

Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats.

C Gustafson-Svärd1, I Lilja, O Hallböök, R Sjödahl.   

Abstract

Increased prostaglandin E2 synthesis is considered important in both human and experimental colon carcinogenesis. It is not known, however, which cyclooxygenase isoenzyme is involved. The aim of this study was to compare the content of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in colorectal cancers with the content in normal colonic specimens. Fifteen human colorectal adenocarcinomas, 35 azoxymethane induced colonic tumours from rats, and specimens of normal colon were analysed by reverse transcription and polymerase chain reaction (RT-PCR). It was found that cyclooxygenase-1 and cyclooxygenase-2 mRNA were increased in azoxymethane induced colonic tumours, compared with specimens taken adjacent to the tumours or from the macroscopically normal intestine distant from the tumours. Cyclooxygenase-1 and cyclooxygenase-2 mRNA were increased in specimens from the macroscopically normal intestine of azoxymethane treated animals, compared with colonic specimens from saline treated rats. Cyclooxygenase-2 mRNA, but not cyclooxygenase-1 mRNA, was increased in human colorectal cancers, compared with the adjacent mucosa or macroscopically normal mucosa distant from the tumours. The results suggest that cyclooxygenase-2 is involved in the increased prostaglandin E2 synthesis in colonic cancers, and that activation of this isoenzyme is an early event in colon carcinogenesis. However, cyclooxygenase-1 may also be involved, at least in experimental colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566864      PMCID: PMC1382983          DOI: 10.1136/gut.38.1.79

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

1.  Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2.

Authors:  A Habib; C Créminon; Y Frobert; J Grassi; P Pradelles; J Maclouf
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

Review 2.  Mammalian non-pancreatic phospholipases A2.

Authors:  I Kudo; M Murakami; S Hara; K Inoue
Journal:  Biochim Biophys Acta       Date:  1993-11-03

3.  Effects of endotoxin and dexamethasone on group I and II phospholipase A2 in rat ileum and stomach.

Authors:  I Lilja; J Dimberg; R Sjödahl; C Tagesson; C Gustafson-Svärd
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

4.  Regulation of prostaglandin endoperoxide synthase gene expression in rat mesangial cells by interleukin-1 beta.

Authors:  D Rzymkiewicz; K Leingang; N Baird; A R Morrison
Journal:  Am J Physiol       Date:  1994-01

5.  Aspirin use and lung, colon, and breast cancer incidence in a prospective study.

Authors:  D M Schreinemachers; R B Everson
Journal:  Epidemiology       Date:  1994-03       Impact factor: 4.822

6.  Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression.

Authors:  L Feng; W Sun; Y Xia; W W Tang; P Chanmugam; E Soyoola; C B Wilson; D Hwang
Journal:  Arch Biochem Biophys       Date:  1993-12       Impact factor: 4.013

7.  Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine.

Authors:  E Mereto; L Frencia; M Ghia
Journal:  Cancer Lett       Date:  1994-01-15       Impact factor: 8.679

8.  Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

Authors:  L J Crofford; R L Wilder; A P Ristimäki; H Sano; E F Remmers; H R Epps; T Hla
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

9.  Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon.

Authors:  C V Rao; B Simi; B S Reddy
Journal:  Carcinogenesis       Date:  1993-11       Impact factor: 4.944

10.  Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency.

Authors:  S Yamashita; J Yamashita; M Ogawa
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more
  16 in total

Review 1.  Aspirin and other anti-inflammatory drugs.

Authors:  S J Vane
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 2.  Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer.

Authors:  Milind Rao; Wenxuan Yang; Alexander M Seifalian; Marc C Winslet
Journal:  Int J Colorectal Dis       Date:  2003-06-03       Impact factor: 2.571

3.  Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells.

Authors:  C Jobin; O Morteau; D S Han; R Balfour Sartor
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

4.  Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation.

Authors:  W A Brown; S A Skinner; C Malcontenti-Wilson; D Vogiagis; P E O'Brien
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

5.  Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

Authors:  B K Reuter; S Asfaha; A Buret; K A Sharkey; J L Wallace
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

6.  Cyclooxygenase-2 expression in colorectal cancer liver metastases.

Authors:  M A Hull; S W Fenwick; K S Chapple; N Scott; G J Toogood; J P Lodge
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

7.  Expression of cyclooxygenase-2 protein in colorectal carcinomas.

Authors:  Young-Eun Joo; Hyun-Soo Kim; Sang-Woon Min; Wan-Sik Lee; Chang-Hwan Park; Chang-Soo Park; Sung-Kyu Choi; Jong-Sun Rew; Sei-Jong Kim
Journal:  Int J Gastrointest Cancer       Date:  2002

8.  Modulation of base hydroxylation by bile acids and salicylates in a model of human colonic mucosal DNA: putative implications in colonic cancer.

Authors:  H Allgayer; M Kolb; V Stuber; W Kruis
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

9.  Localization of cyclooxygenase-2 in human sporadic colorectal adenomas.

Authors:  K S Chapple; E J Cartwright; G Hawcroft; A Tisbury; C Bonifer; N Scott; A C Windsor; P J Guillou; A F Markham; P L Coletta; M A Hull
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 10.  Chemoprevention of colorectal cancer.

Authors:  M Langman; P Boyle
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.